Transcatheter heart valve interventions for patients with rheumatic heart disease
Rheumatic heart disease [RHD] is the most prevalent cause of valvular heart disease in the world, outstripping degenerative aortic stenosis numbers fourfold. Despite this, global resources are firmly aimed at improving the management of degenerative disease. Reasons remain complex and include lack o...
Main Authors: | Hellmuth Weich, Philip Herbst, Francis Smit, Anton Doubell |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2023-09-01
|
Series: | Frontiers in Cardiovascular Medicine |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fcvm.2023.1234165/full |
Similar Items
-
FREQUENCY OF RHEUMATIC HEART DISEASE IN PATIENTS UNDERGOING ECHOCARDIOGRAPHY IN DISTRICT DERA ISMAIL KHAN
by: Amjad Abrar, et al.
Published: (2015-01-01) -
Transcatheter Mitral Valve Replacement in the Transcatheter Aortic Valve Replacement Era
by: Luca Testa, et al.
Published: (2019-11-01) -
Assessment of mitral regurgitation and mitral complex geometry in patients after transcatheter aortic valve implantation
by: Danuta Sorysz, et al.
Published: (2020-10-01) -
Editorial: Transcatheter mitral and tricuspid valve therapies
by: Omar Chehab, et al.
Published: (2023-12-01) -
What Is the Next Generation of Transcatheter Mitral Valve Repair Devices?
by: Mi Chen, et al.
Published: (2021-02-01)